WeedLife News Network

The U.S. Food and Drug Administration (FDA) has granted GW Pharmaceuticals Plc's experimental cannabis-derived epilepsy drug "orphan" status for a third group of patients affected by a rare form of the disease.

Since relocating to the US, the positive changes in Tristan’s condition and well-being have convinced Yvonne that her desperate decision to leave their home in Ireland was the right one.

A new law legalizes cannabis oil to help some Texans who have intractable epilepsy. If plans move forward, cannabis oil could be available for some epileptic Texans by late 2017.

An experimental drug derived from marijuana has succeeded in reducing epileptic seizures in its first major clinical trial, the product’s developer announced Monday, a finding that could lend credence to the medical marijuana movement.

AURORA, Colo. - A baby girl who began having life-threatening seizures within days of her birth is receiving hemp oil while in the neonatal intensive-care unit at Children's Hospital Colorado, her mother says.

A new study involving 11 epilepsy centers across the United States shows that a drug made from a medical marijuana derivative can reduce seizures in children and young adults with epilepsy who don't find relief from other treatments.

GW Pharmaceuticals, which makes drugs derived from the cannabis plant, is scaling up its manufacturing capacity ahead of an expected approval of a new treatment for children with life-threatening epilepsy.

Each morning, Kim Hearn attaches a feeding tube to her son before outfitting him in specialized clothes that lend support to his torso, ankles and legs.

Hannah Loew, a child who suffers from a severe form of epilepsy called Dravet Syndrome, is among dozens who have moved to Colorado to receive higher concentrated doses of marijuana.